Case Report: Alpha6 Integrin Disorder Presenting in Childhood with Nail Dysplasia and Onycholysis But No History of Fragile or Bullous Skin Changes

Alayna N. Zalesny, Sarah Gunter, Charles A. Williams

Global Medical Genetics ›› 2024, Vol. 11 ›› Issue (04) : 344-348.

PDF(1264 KB)
PDF(1264 KB)
Global Medical Genetics ›› 2024, Vol. 11 ›› Issue (04) : 344-348. DOI: 10.1055/s-0044-1791804
Case Report
research-article

Case Report: Alpha6 Integrin Disorder Presenting in Childhood with Nail Dysplasia and Onycholysis But No History of Fragile or Bullous Skin Changes

Author information +
History +

Abstract

We report a 7-year-old girl born with pyloric atresia but without congenital epidermolysis bullosa or skin fragility. Nail dysplasia developed at age 8 months and throughout childhood she suffered from onycholysis and mild nail hypertrophy. Whole-exome sequencing demonstrated biallelic mutations in alpha6 integrin (ITGA6): p. Q139* and R153W. ITGA6 normally forms a protein heterodimer with beta4 integrin (ITGB4), and this dimer participates in anchoring the basal skin cells to the extracellular matrix. Biallelic mutations in each gene are well known to cause epidermolysis bullosa and pyloric atresia. However, this child had ostensibly normal skin without any evidence of skin fragility. In a literature search, we identified 11 cases involving ITGA6 mutations, and all had epidermolysis skin changes. Thus, this case adds to the reported phenotype of ITGA6 disease since it is the first to show absence of an epidermolysis bullosa phenotype in the setting of pyloric atresia and nail dysplasia.

Keywords

ITGA6 / onycholysis / nail dysplasia

Cite this article

Download citation ▾
Alayna N. Zalesny, Sarah Gunter, Charles A. Williams. Case Report: Alpha6 Integrin Disorder Presenting in Childhood with Nail Dysplasia and Onycholysis But No History of Fragile or Bullous Skin Changes. Global Medical Genetics, 2024, 11(04): 344‒348 https://doi.org/10.1055/s-0044-1791804

References

[1]
Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010; 339(01) 269-280
[2]
Dang N, Klingberg S, Rubin AI, et al. Differential expression of pyloric atresia in junctional epidermolysis bullosa with ITGB4 mutations suggests that pyloric atresia is due to factors other than the mutations and not predictive of a poor outcome: three novel mutations and a review of the literature. Acta Derm Venereol 2008; 88(05) 438-448
[3]
Lucky AW, Gorell E. Epidermolysis Bullosa with Pyloric Atresia. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews((R)). Seattle, WA: University of Washington, Seattle; 1993
[4]
Schumann H, Kiritsi D, Pigors M, et al. Phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations. Br J Dermatol 2013; 169(01) 115-124
[5]
Allegra M, Gagnoux-Palacios L, Gache Y, et al. Rapid decay of alpha6 integrin caused by a mis-sense mutation in the propeller domain results in severe junctional epidermolysis bullosa with pyloric atresia. J Invest Dermatol 2003; 121(06) 1336-1343
[6]
Chung HJ, Uitto J. Epidermolysis bullosa with pyloric atresia. Dermatol Clin 2010; 28(01) 43-54
[7]
Gache Y, Romero-Graillet C, Spadafora A, et al. A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination. J Invest Dermatol 1998; 111(05) 914-916
[8]
Ghazzawi RA, Fatma A. Epidermolysis bullosa with pyloric stenosis: a novel lethal variant. Cureus 2023; 15(06) e41167
[9]
Masunaga T, Ogawa J, Akiyama M, Nishikawa T, Shimizu H, Ishiko A. Compound heterozygosity for novel splice site mutations of ITGA6 in lethal junctional epidermolysis bullosa with pyloric atresia. J Dermatol 2017; 44(02) 160-166
[10]
Pulkkinen L, Kimonis VE, Xu Y, Spanou EN, McLean WH, Uitto J. Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet 1997; 6(05) 669-674
[11]
Ruzzi L, Gagnoux-Palacios L, Pinola M, et al. A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest 1997; 99(12) 2826-2831
[12]
Wee LWY, Tan EC, Bishnoi P, et al. Epidermolysis bullosa with pyloric atresia associated with compound heterozygous ITGB4 pathogenic variants: Minimal skin involvement but severe mucocutaneous disease. Pediatr Dermatol 2021; 38(04) 908-912
[13]
Lépinard C, Descamps P, Meneguzzi G, et al. Prenatal diagnosis of pyloric atresia-junctional epidermolysis bullosa syndrome in a fetus not known to be at risk. Prenat Diagn 2000; 20(01) 70-75
[14]
Martin B. Nail histopathology. Actas Dermosifiliogr 2013; 104(07) 564-578
[15]
OMIM (Online Mendelian Inheritance in Man): Nail Disorder, Nonsyndromic Congenital 1; NDNC1, # 161050, edit 03/17/2020. Accessed September 27, 2024 at: https://omim.org/entry/161050
[16]
Walko G, Castañón MJ, Wiche G. Molecular architecture and function of the hemidesmosome. Cell Tissue Res 2015; 360(02) 363-378
[17]
Pohla-Gubo G, Lazarova Z, Giudice GJ, et al. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa. Exp Dermatol 1995; 4(4 Pt 1): 199-206

RIGHTS & PERMISSIONS

2024 Global Medical Genetics
PDF(1264 KB)

Accesses

Citations

Detail

Sections
Recommended

/